Nuvama cuts Aurobindo Pharma target to Rs 1,485 but retains ‘Buy' on healthy EBITDA margin
By News Desk Published on May 28, 2025, 08:26 IST
Nuvama Institutional Equities has retained its Buy rating on Aurobindo Pharma (ARBP) but revised its target price down to ₹1,485 from ₹1,677, citing a mixed Q4 performance and a cautious FY26 outlook.
The brokerage said revenue and adjusted EBITDA beat expectations, but PAT (profit after tax) missed estimates. Nuvama noted that the adjusted EBITDA margin of 22.6% was better than anticipated, reflecting effective cost control and operational efficiency.
The management has guided for single-digit growth and flat margins in FY26, while FY27 is expected to benefit from new product launches and biosimilar contributions in Europe. This could support stronger performance in the medium term.
Despite the margin outperformance, Nuvama has reduced its PAT estimates for FY26E and FY27E by 5% and 4% respectively, factoring in lower earnings visibility and conservative growth assumptions.
The report also flagged a potential future trigger in the form of a government announcement on minimum input price for PLI (Production Linked Incentive) scheme products, which could support sector margins.
Disclaimer: The views and recommendations expressed above are those of the brokerage firm. Business Upturn does not endorse or offer any investment advice.
News desk at BusinessUpturn.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Upturn
4 hours ago
- Business Upturn
Morgan Stanley on Indian steel stocks: Rally driven by strong demand, imports may rise again
By News Desk Published on June 2, 2025, 08:14 IST Morgan Stanley has shared a fresh update on the Indian steel sector, flagging both near-term positives and risks for the industry. The brokerage noted that Indian steel remains about 15% more expensive than imported steel, even after factoring in import duties. Steel imports into India have decreased recently, helping local steel prices stay firm. However, imports might rise again if the price gap persists, which could weigh on domestic pricing power going forward. At the same time, Indian steel stocks have rallied recently, led by strong domestic demand trends. Morgan Stanley also pointed to positive news from China, where policy signals suggest potential cuts in Chinese steel supply — which, if sustained, could provide further support to global steel prices and sentiment for Indian players. Overall, while domestic demand is a tailwind for Indian steel stocks, Morgan Stanley will be closely monitoring trends in imports, global supply, and pricing spreads to gauge the sustainability of the current rally. Disclaimer: This article is for informational purposes only and does not constitute investment advice. News desk at
Business Upturn
4 hours ago
- Business Upturn
Stock Market: Morgan Stanley says India GDP growth of 7.4% beats expectations, sees risks from global demand
By News Desk Published on June 2, 2025, 08:12 IST Morgan Stanley remains positive on the Indian economy, after the latest GDP print showed growth of 7.4%, while Gross Value Added (GVA) growth came in at 6.8% — both higher than earlier expectations. The brokerage highlighted that the growth was led by improved industrial activity, with manufacturing and construction sectors contributing strongly to the upside. However, Morgan Stanley also cautioned that growth may moderate going forward, given the backdrop of weak global demand. It further noted that it is closely monitoring domestic policy trends as well as potential impacts from global tariffs, which could shape the near-term growth trajectory. Overall, Morgan Stanley remains constructive on India's macro outlook but flagged the need to watch for external risks and policy dynamics in the quarters ahead. Disclaimer: This article is for informational purposes only and does not constitute investment advice. News desk at
Business Upturn
3 days ago
- Business Upturn
Donald Trump accuses China of violating trade deal, says US tariffs had pushed China into ‘grave economic danger'
By News Desk Published on May 30, 2025, 17:45 IST Former US President Donald Trump on Thursday claimed that China had been on the brink of severe economic trouble due to the tariffs imposed during his administration, and accused Beijing of violating a trade agreement made to ease the crisis. In a post on Truth Social, Trump wrote that the high tariffs made it 'virtually impossible' for China to trade into the US market, calling the action equivalent to going 'COLD TURKEY' with China. He said this led to widespread factory closures and 'civil unrest' in China. Trump further stated that he had intervened by negotiating a 'FAST DEAL' to stabilize the situation, not for the US but to prevent a deeper crisis in China. 'Everything quickly stabilized and China got back to business as usual,' he wrote. However, Trump sharply criticized China for what he called a breach of that agreement. 'The bad news is that China, perhaps not surprisingly to some, HAS TOTALLY VIOLATED ITS AGREEMENT WITH US,' he said, ending his post with: 'So much for being Mr. NICE GUY!' Trump's comments come amid renewed tensions in US-China trade relations as Washington weighs additional tariffs on Chinese goods. News desk at
